We describe a group of Drosophila cDNAs that encode MADS box proteins and which are members of the MEF2 (myocyte enhancer-bindingfactor 2) family of transcription factors. Drosophila has a single MEF2 gene, DMEFZ, that is alternatively spliced to produce different transcripts and which is expressed in the mesodermal primordium before gastrulation. The mechanisms responsible for the subsequent subdivision of the mesoderm are unknown. However, DMEFZ may play a role in this important event because our experiments show that it is a downstream target for twist and that its early expression pattern modulates as the mesoderm is organising into cell groupings with distinct fates. DMEF2 is also expressed in both the segregating primordia and the differentiated cells of the somatic, visceral and heart musculature. It is the only known gene expressed in these three main types of muscle throughout differentiation.
Introdllction
There is a wealth of genetic and molecular information that describes the subdivision of the Drosophila blastoderm into different domains with distinct developmental fates (reviewed in St Johnston and Nusslein-Volhard, 1992) . The embryonic dorsal-ventral axis is defined by a nuclear concentration of the maternally expressed dorsal gene product (reviewed in Chasan and Anderson, 1993) . The highest concentration specifies the mesodermal primordium in the most ventral region, and this is revealed by the expression domains of the zygotic genes twist and snail (Thisse et al., 1987; Leptin and Grunewald, 1990; Alberga et al., 1991) . There is also a substantial body of information, mainly at the morphological and cellular level, that describes the development of the mesoderm from this domain (reviewed in Bate, 1993) . Although twist has a * Corresponding author, Tel.: 0223 336620; Fax: 0223 336676.
key role in the activation of downstream mesodermal genes (Leptin, 1991) , few targets have been identified. Indeed, in general, little is known of the gene functions and molecular mechanisms that underlie the assignation of different groups of mesodermal cells to distinct pathways of differentiation, for example, the body wall or somatic musculature, the gut or visceral musculature and the heart. One line of investigation in the study of the molecular mechanisms of muscle differentiation has been to study muscle gene activation. The intention has been that it should be possible to work back from the events that control the expression of muscle-specific genes to those events involved in cell fate decisions (see, for example, Gurdon et al., 1989) . Much progress has been made in a variety of vertebrate species where the MyoD family of four closely related transcription factors has been shown to occupy a nodal point in skeletal muscle differentiation (Weintraub et al, 1991) . Together with other transcription factors, they activate the transcription of muscle genes through binding to the E-box DNA se-0925~4773/95/$09.50 0 1995 Elsevier Science Ireland Ltd. All rights reserved SSDI 0925-4773(94)00323-F quence motif found in the promoters and enhancers of many muscle genes. They are expressed early in development when muscle cell lineages are defined (Sassoon et al., 1989; Hopwood et al., 1989; de la Brousse and Emerson, 1990 ). Their importance is illustrated both by their ability to convert fibroblasts and a variety of other cells into myoblasts (Davis et a1.,1987; Choi et al., 1990) , and by the severity of the muscle phenotypes in mice with mutations in these genes (Rudnicki et al., 1993; Hasty et al., 1993; Nabeshima et al., 1993) . However, despite its crucial role in skeletal muscle, the MyoD family is not expressed in cardiac and smooth muscle and therefore provides only a partial explanation of muscle gene expression. A second group of vertebrate muscle gene transcription factors, the MEF2 family, has been described more recently that may complement MyoD family function (Pollock and Treisman, 1992; Yu et al., 1993) . MEF2 proteins are members of the MADS family of transcription factors (SchwarzSommer et al., 1990) , whose members have a variety of functions ranging from a response to extracellular signalling to a homeotic role in plant development. Like the MyoD family, the MEF2 proteins activate transcription through a motif, in this case an A-T rich sequence, found in many muscle gene promoters and enhancers (Pollock and Treisman, 1992) . The MEF2 genes are also expressed early in the embryonic development of muscle lineages (Chambers et al., 1992; Edmondson et al., 1994) . Their expression contrasts with that of the MyoD family. Firstly, they are not restricted to skeletal muscle: they are also expressed in cardiac and smooth muscle. Secondly, their expression is not even restricted to the mesoderm: they are also expressed in the nervous system. Although the MEF2 family appears to have an important role in the regulation of muscle gene expression, its function in muscle development is unknown.
Because of the substantial conservation of the molecular mechanisms of development from Drosophila to man, it would be expected that members of the MyoD and MEF2 families would be found in Drosophila. Indeed, Drosophila contains a single member of the MyoD family, nautilus (Michelson et al., 1990; Paterson et al., 1991) . Moreover, nuutilm expression is in some respects analogous to that of the MyoD family. It is restricted to the somatic muscle and is expressed early in single cells, known as founder cells (Michelson et al., 1990; Paterson et al., 1991) , that develop into individual multinucleate muscles after the recruitment of, and fusion with, neighbouring cells (Bate, 1990) . However, it is not yet established whether or not the function of nautilus is also analogous to that of the vertebrate MyoD family. Nevertheless, it is clear that in Drosophila transcription factors other than nautilus must activate muscle gene transcription in muscle cells where it is not expressed.
In this paper, we describe the isolation of cDNAs encoded by the Drosophila MEF2 gene and the temporal and spatial pattern of expression of this gene throughout embryonic development. Because of the importance of twist in mesoderm development, we compare the DMEF2 expression pattern with that of twist and also report the influence of twist on DMEF2 expression. Our studies show that DMEF2 is a downstream target of twist and suggest that DMEF2 may play a role in the subdivision of the mesoderm into cells assigned to distinct differentiation pathways. Furthermore, the expression of DMEF2 in both the primordia and differentiated cells of the somatic, visceral and heart musculature is consistent with a role throughout the differentiation of each of these different muscle types.
Results

Isolation and DNA sequencing of DMEF2 cDNA
A 4-8-h-Drosophila-embryo cDNA library was screened with a probe that encompasses the conserved DNA-binding and dimerisation domain of Xenopus SL-1, which is the frog homologue of human MEF2D (Chambers et al., 1992; Breibart et al., 1993) . Twenty two positive cDNA clones were isolated from 200 000 colonies screened. These cDNAs were analysed by restriction mapping and the nucleotide sequence of one of them is shown in Fig. 1A .
The longest open reading frame, which is flanked by stop codons, encodes 516 amino acids starting with the first methionine in this sequence. The putative initiation codon does not conform well to the Drosophila translation start site consensus (Cavener, 1987) . Nevertheless, the alignment of our putative DMEF2 protein sequence with the amino acid sequences of MEF2 family members from other species shows a striking degree of sequence similarity starting at this methionine in the first 86-amino acids of the N-terminus domain. In those members of the MADS family of transcription factors where it has been tested, this domain contains the DNA binding and dimerisation activities of the protein (Norman et al., 1988; Pollock and Treisman, 1992; Yu et al., 1993; Sharrocks et al., 1993) . MEF2 proteins are members of the MADS family, but contain an additional region of 29 highly conserved amino acids immediately downstream of the 55 amino acid MADS box (Pollock and Treisman, 1992) . The sequence similarity between DMEF2 and other MEF2 proteins extends through this region, identifying DMEFZ as a MEF2 protein and not simply a member of the MADS box family. DMEFZ is identical to SLl (Xenopus MEF2D) in 76 positions of the 86 amino acid N-terminal domain and in 73-76 positions of this domain in the four human MEF2 proteins (Fig. 2) . Despite this very high percentage of sequence identity, outside this domain there is little similarity between DMEF2 and other MEF2 sequences (not shown). Near its C-terminus, DMEF2 contains a polyglutamine stretch encoded by repeats of the (Chambers et al., 1992) , the four human MEFZ proteins (Yu et al., 1992; Pollock and Treisman, 1991; McDermott et al., 1993; Breibart et al., 1993) , Drosophila SRF (ABolter et al., 1994) and human SRF (Norman et al., 1988) . The nomenclature for the human MEFZ proteins is that suggested in Breibart et al. (1993) . The MADS box is at the N-terminus of the various MEF2 proteins, whereas it occupies a more central position in the SRF proteins. Conserved amino acids are indicated by boxes. All the conserved amino acids of the MADS box are present in both the MEFZ and SRF protein sequences.
nucleotide triplet CAX. CAX repeats, also known as an opa repetitive element (Wharton et al., 1985) , are found in many Drosophila genes although their significance is unclear. The role of this region in DMEF2 awaits analysis, however we note that several vertebrate MEF2 proteins also contain glutamine-rich regions towards the
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C-terminus and that this is a recognised feature of transcriptional activation domains (Mitchell and Tjian, 1989) . Our DMEFZ cDNA has long untranslated sequences at both its 5 ' and 3 ' ends, but may be a few hundred bases short of full-length, since Northern blots suggest that the DMEF2 RNA is approximately 3.6 kb (Fig. 4) . Although the cDNA contains 14 A residues at its 3 ' end, there is no polyA addition signal consensus sequence and so the true polyA tail may be further 3 '. In common with the mammalian MEF2 genes (Yu et al., 1992; McDermott et al., 1993; Breibart et al., 1993) , we found that DMEF2 is alternatively spliced. Restriction mapping and sequencing of the relevant region of five other cDNA clones showed that there are two splicing events, one towards the middle of the coding sequence and one towards its 3' end ( Fig. 1) . The first at position 1597 results in the inclusion or exclusion of an 18-bp exon. The second at position 2422 results in the inclusion of a 21-bp or a 7%bp exon, or the exclusion of both. We believe that these sequences represent alternative exons rather than unspliced introns because they do not contain the conserved sequence features of introns. Moreover, in each case, they maintain the open reading frame and so each protein will have the same sequence either side of the splice site, but those with extra exons will have short additional peptide sequences inserted (see Fig. 1 ).
Genomic Southern and chromosomal localisation of DMEF2
A genomic Southern blot hybridised with a probe spanning the conserved MADSLMEF2 domain detected only a single band in each lane at both low stringency ( Fig. 3A ) and high stringency (not shown). This suggests that there is only a single gene closely related to DMEF2 in the Drosophila genome. Substantial over-exposure of the low stringency blot does, however, reveal a number of other faint bands indicating the presence of genes more distantly related to DMEFZ (not shown). The cytological location of the DMEFZ gene was determined using the same probe. The signal of the single band detected maps within the interval 46B12 to C12, most probably to 46C1,2 (Fig. 3B ).
The temporal expression of DMEF2
A Northern blot shows that DMEF2 RNA is approximately 3.6 kb in length and is expressed throughout embryogenesis (Fig. 4) . The highest level of expression is at 4-8 and 8-12 h, which correlates with the period when most of the events of mesoderm differentiation and, in particular, somatic muscle differentiation are occurring (Bate, 1990; Bate, 1993) . DMEF2 is expressed before nautilus, the Drosophila MyoD family member, which is first detectable by Northern blot at 4-8 h (Michelson et al., 1990) . The probe used spans the conserved MEF2 domain of the cDNA and will detect the DMEF2 splicing variants of which we are aware. Because the altemative exons are short, the transcripts will not differ greatly in size and so the different splicing variants would not be resolved in this experiment.
The embryonic expression pattern of DMEF2
DMEF2 RNA was detected in Drosophila embryos using a whole mount in situ hybridisation procedure. DMEF2 expression is first apparent ventrally in the cellular blastoderm (stage 5) in the mesodermal primordium. At this stage and as gastrulation commences (stage 6, Fig. 5A ), DMEF2 is not uniformly expressed, but rather has seven stripes of high expression, which suggests a pair rule gene-like input into this early pattern.
After gastrulation (stage 7) and during the early stages of germ band extension (stages 8 and 9), the cells of the mesoderm begin to spread dorsally, eventually to form Fig. 5 . The Iocalisation of DMEFZ RNA in wild type OR embryos detected by in situ hybridisation. We have ascribed the stages of embryonic development according to the scheme of Campos-Ortega and Hartenstein (1985) . Anterior is to the left in all cases except (F) and (G) in which it is at the top and in lateral views, dorsal is uppermost. All photographs were taken with bright field optics except (F) and (G) which were with Nomarski optics. Head expression is out of focus at many stages. a single layer (Campos-Ortega and Hartenstein, 1985) .
visceral musculature (Fig. 5H) . There also appears to be In stages 7 and 8, DMEF2 is expressed pan-meso-DMEF2 expression in other cells in this internal dodermally (Fig. 5B ), but during stage 9 the DMEF2 RNA main. These cells may contribute to the fat body distribution begins to become less uniform and enters a (MBate, personal communication), although we cannot very dynamic phase (Fig. 5C ). Expression is now much detect expression in the fat body later at stage 13 (not higher in the dorsal region than more ventrally. This shown). At stage 12, as germ band retraction comdorsal restriction of DMEF2 is reminiscent of tinman, mences, the DMEF2 expression pattern has modulated which is a gene required for the formation of the heart further ( Fig. 51) . In contrast to stages 10 and 11, the and visceral mesoderm and of some specific somatic external cells of the mesoderm now have a much higher muscles (Bodmer et al., 1990, Azpiazu and Frasch, 1993;  level of DMEF2 expression than the internal cells. These Bodmer, 1993) . Towards the end of stage 9, DMEF2 external cells include the progenitors of the various resolves into patches of high expression within this dorgroups of somatic muscles and the cells that will fuse sal region (Fig. SD) . There are also stripes of DMEF2 with them to make the mature muscles. Nevertheless, expression, l-2 cells in diameter, that extend back DMEFZ is still expressed in the cells forming the visceral towards the mid-line. In addition, there is expression in musculature, the mesodermal cross-bridges, the heart the hindgut primordium and in the head. and the pharyngeal muscles. During stage 10, the mesoderm undergoes a substantial reorganisation. The principle feature is the separation into two cell layers, an external layer and an internal layer: the somatic muscles derive from the external layer, that closest to the ectoderm, and the visceral muscles derive from the internal (Campos-Ortega and Hartenstein, 1985; Bate, 1993) . The heart derives from the most dorsal external cells (Azpiaxu and Frasch, 1993) . The mesoderm is now also separated ventrally, but remains linked in each segment by a cross-bridge of mesodermal cells that traverses the mid-line (Bate, 1993) . In parallel with all these morphological changes, the pattern of DMEF2 expression also evolves substantially. Most noticeably, dorsal, DMEF2expressing cells, initially one per abdominal hemisegment, are now apparent ( Fig. 5E and F ) and appear to have emerged from the dorsal strip of DMEF2 expression seen at stage 9 (Fig. 5D ). These cells resemble, and may be the same as, the even-skipped expressing cells, which are precursors of the heart (Frasch et al., 1987; Azpiazu and Frasch, 1993; Bodmer, 1993) . Other single cells, or small groups of cells, expressing DMEF2 also become apparent, both laterally and ventrally, at this time. These include, early in stage 11 in the ventral region overlying the nervous system, a group of three isolated cells, one group per abdominal hemisegment ( Fig. 5H and G) . These cells are in the expected position of somatic muscle founders. At the same stage and in a similar position to these DMEF2 expressing groups, there is one ventral nautilus expressing putative muscle founder cell (Michelson et al., 1990) .
After germ band retraction, when much mesodermal cell differentiation is complete, DMEF2 continues to be expressed in the various muscle types (stage 13, Fig. 5J and K) and its pattern of expression now resembles that of muscle myosin (Lai et al., 1993; Bate, 1993) . DMEF2 is expressed in the three major groups of somatic muscles, the dorsal, the lateral and the ventral. Indeed, it may be expressed in all the somatic muscles, both before and after cell fusion. Moreover, DMEF2 is still expressed in the pharyngeal muscles of the head and visceral musculature of the oesophagus, fore-gut, mid-gut and hind-gut. In addition, DMEF2 continues to be expressed in the heart. Before dorsal closure, DMEF2-expressing heart precursors are seen in a well-defined strip of cells located dorsally to the blocks of somatic muscle (Fig. 5J) . As dorsal closure proceeds, these strips of cells from each side of the embryo come together to form the heart (Fig. 5L and M) . The heart is composed of cardioblasts and pericardial cells (Campos-Ortega and Hartenstein, 1985) : DMEFZ, like muscle myosin, is only expressed in the former.
The relationship between DMEF2 and twist
There are other striking changes in DMEF2 expression during stages 10 and 11. DMEF2 expression modulates such that as the two mesodermal cell layers are forming, it becomes elevated in the internal cells relative to those lying more externally. This pattern has evolved from the segmentally-repeated domains of expression seen late in stage 9 (Fig. 5D ) which are evident before any morphological indication of the formation of two cell layers. By stage 11, there is prominent expression in the distinctive arches of the progenitors of the Twist is required for the activation of specific genes in the mesoderm (Leptin, 1991) and in the period before germ band retraction (stage 12), its widespread expression has been used as a foundation for a description of mesoderm development (Bate, 1993) . For these reasons, it is informative to compare the pattern of expression of DMEFZ with that of twist. We investigated the relationship between these patterns in detail using a doublelabelling technique that detected DMEF2 RNA and Twist protein. It is clear that the two patterns of expression share some features, yet differ in others.
Although both DMEFZ and twist are expressed in the mesodermal primordium in the cellular blastoderm, DMEF2 is not expressed as far anteriorally as twist (Figs. 5A and 6A) . Also, at this stage DMEF2 RNA has stripes of higher expression (Fig. SA) , whereas Twist protein appears to be expressed uniformly ( Fig. 6A ; Leptin and Grunewald, 1990) . After the invagination of the mesodermal primordium at gastrulation and during the early phase of germ band extension, both DMEF2 RNA and Twist protein are expressed uniformly in the mesoderm. However, as the two patterns of expression refine during the subsequent reorganisation of the mesoderm, differences become apparent.
The first of these is during stage 9 when DMEF2 expression becomes much higher dorsally than more ven&ally (Fig. 5C ), whereas Twist continues to be expressed throughout the mesoderm (Thisse et al., 1988; Leptin and Grunewald, 1990 ). Shortly after, there is modulation along the anterior/posterior (A/P) axis of the expression patterns of both DMEF2, as we have shown (Fig. 5D, E and H) , and twist, as previously demon- strated (Bate, 1993) . However, at stages 10 and 11, our experiments show that the two patterns are largely out of register (Fig. 6B-D) . Twist is expressed at a higher level in the mesodermal cells that will give rise to the somatic muscles. In contrast, DMEF2 expression is higher in between these patches of high Twist expression in a region of cells that moves into the embryo and will give rise to the visceral musculature (Bate, 1993 ; 0. DuninBorkowski, N. Brown, M. Bate, personal communication). In addition, at stages 10 and 11, DMEFZ is highly expressed in cells at the dorsal boundary of the twist domain, which contribute to the heart, and also together with twist in the mesodermal cross bridges.
By early stage 12, there is a dramatic change in the relationship between these genes. Although both DMEFZ and twist are still modulated along the A/P axis, their expression now overlaps to a large extent (Fig. 6E) . DMEFZ expression is now much stronger in the somatic muscle precursors, where twist continues to be expressed and is relatively weak in the visceral musculature. Twist is no longer detected in the cross bridges, whereas DMEF2 is still strongly expressed there. Later in embryonic development, beginning at germ band retraction (stage 12), twist expression declines dramatically, eventually persisting only in the precursors of the adult muscles ( Fig. 6F ; Bate et al., 1991) . In contrast, during these stages, DMEF2 continues to be strongly expressed throughout the somatic, visceral and heart musculature (Figs. 5J,K and 6F).
DMEF2 expression is dependent on twist fiction
The pattern of DMEF2 expression up to the end of germ band retraction shares some of the features of twist expression but differs in others. We began to investigate the complex relationship between DMEF2 and twist by analysing DMEF2 expression in twist mutant embryos at three different stages (Fig. 7) . No DMEFZ expression is detected in older twist embryos (Fig. 7C) , which is expected because the mesoderm has failed to develop (Simpson, 1983) . Localised transient expression is found, however, in the area of the developing hindgut in 5-6 h twist embryos (Fig. 7B) . We are unsure of the significance of this DMEF2 expression, but it may be related to the myosin expression reported in the visceral mesoderm surrounding the hind-gut of twist embryos (Younossi-Hartenstein and Hartenstein, 1993) . Importantly, we detect no DMEFZ expression just prior to and at gastrulation in twist embryos (Fig. 7A) . Because twist activity at this time is essential for twist-dependent activation of downstream mesodermal genes (Leptin, 1991) , this suggests a more direct effect of twist on DMEF2 expression.
We therefore wished to test whether Twist directly influences the expression of DMEFZ. Twist can induce expression of the early mesodermal gene tinmun (M.B. and M.Bate, unpublished results) and so we repeated the experiment, this time testing whether DMEF2 expression could be induced. Neither Twist nor DMEF2 is normally expressed in the epidermis. However, when ectopic Twist expression is induced there, then we can detect subsequent DMEFZ expression in these same cells (Fig. 7D) . The appearance of DMEFZ RNA only 1.5 h after heat shock is consistent with a direct activation of DMEF2 by Twist, given the indirect nature of the GAL4 system used to induce Twist expression (see Experimental procedures).
Discussion
We have described the isolation and characterisation of DMEF2. Its sequence and expression pattern suggest it is a homologue of the mammalian MEF2 family of transcription factors. DMEF2 joins a small number of genes known to be expressed in, and restricted to, the mesoderm during the period between the specification of the mesodermal primordium and the organisation of the mesoderm into groups of cells with distinct fates. The function of the MEF2 family in development is unknown, however, our studies of DMEF2 expression suggest that this family member may have a number of important roles. Although its expression pattern is complex, it has two features that together distinguish it from other known mesodermal genes and which suggest that DMEFZ may be of particular significance. Firstly, its early expression pattern modulates in groups of cells adopting specific developmental fates. Secondly, DMEF2 is expressed later in the differentiating cells of the three main types of muscle: somatic, visceral and heart.
Expression and possible roles of DMEFZ
In current understanding of the subdivision of the Drosophila mesoderm, twist and tinman are the two genes that occupy centre stage. twist is required for mesoderm formation (Simpson, 1983) and later has a second role in the development of the embryonic somatic muscles (M.B. and M. Bate, unpublished results) . tinmm is required for the development of the heart and visceral musculature and also for some somatic muscles (Azpiazu and Frasch, 1993; Bodmer, 1993) . Whilst there are obvious differences between the pattern of DMEF2 expression and that of twist and tinman, there are some important similarities. Like them, DMEF2 is expressed early in the mesodermal primordium and then, later, its expression pattern relines as the mesodermal cell layer reorganises into groups of cells with specific developmental fates. An early refinement is that both DMEF2 and tinman become dorsally restricted during stage 9. The dorsal restriction of tinmun expression is suggested to be one of the earliest steps in the spatial subdivision of the mesoderm (Azpiazu and Frasch, 1993; Bodmer, 1993) . Shortly after, the expression of both DMEF2 and twist is dramatically modulated along the A/P axis. This modulation marks cells that have distinct developmental fates as the two layers of the mesoderm form (Bate, 1993; 0. Dunin-Borkowski, N. Brown, M. Bate, personal communication) . DMEF2 expression is initially high in the cells that will form the visceral muscle, but later is high in those that will form the somatic muscle. The cells that will form the heart, which are at the dorsal extreme of the external mesodermal cell layer (Azpiazu and Frasch, 1993) , also express DMEF2. We note that the temporal expression of DMEF2 in these primordia is highly dynamic and could correlate with particular events in cell determination and differentiation pathways. In particular, the initial A/P modulation of DMEFZ expression precedes any morphological indication of the formation of the two mesodermal cell layers. This is consistent with a role for DMEF2, like twist and tinmun, in the control of cell fate in the mesoderm. Also like twist and tinmn, DMEF2 encodes a putative transcription factor and could therefore coordinate gene expression in one or more mesodermal cell type.
As well as being expressed in the primordia of the somatic and the visceral musculature and the heart, DMEF2 is also expressed subsequently in the differentiating cells of each of these three muscle types. Here it could function in regulating muscle gene expression during the differentiation of each cell type and contrasts with the MyoD-family member nautilus which could not fill such a role since it is only expressed in a subset of the somatic muscles (Michelson et al., 1990) . If DMEF2 has a number of roles during embryonic development, it may achieve this through the interaction with various homeobox-containing transcription factors, which is a feature of other MADS box containing proteins (Grueneberg et al., 1992; Smith and Johnson, 1992) . Although an assessment of these roles of DMEF2 awaits a thorough genetic analysis, the DMEFZ expression pattern is striking. Moreover, DMEF2 is noteworthy as the only gene described that is expressed in both the segregating primordia and the differentiated cells of the three main types of muscle: somatic, visceral and heart.
Regulation of DiUEF2 expression
We demonstrate that around the time of gastrulation, twist is an activator of DMEF2 expression. At gastrulation, there is no detectable DMEF2 expression in twist embryos and ectopic expression of DMEF2 can be induced rapidly by ectopic expression of Twist. Together with the fact that during normal development DMEF2 is expressed in the mesodermal primordium shortly after twist, these results are consistent with the view that DMEF2 is a direct downstream target for Twist. There may, however, be other inputs into DMEF2 expression immediately before and during gastrulation, because we detect stripes of high DMEFZ expression despite approximately uniform expression of Twist (Thisse et al., 1988; Leptin and Grunewald, 1990) . Although not previously commented upon, published work on the initial expression of twist and tinman RNA also shows stripes of higher expression in the blastoderm (Leptin, 1991; Bodmer et al., 1990) . This may indicate a pair-rule input into the expression of a number of genes expressed in the mesodermal primordium. Such an input has been suggested later for bagpipe expression, which is expressed from stage 10 in the dorsal mesoderm (Azpiazu and Frasch, 1993) .
As the germ band extends, the relationship between twist and DMEF2 expression appears to change. Our double-labelling experiments show that despite some similarities in their patterns of expression, there are many instances where their expression is not coincident. It appears, therefore, that during germ band extension there may be a complex relationship between twist and DMEF2 expression. Certainly, at some point, there must be a transition between the situation around gastrulation when twist activates DMEF2, and later after germ band retraction when much DMEF2 expression must be independent of twist, because there is widespread expression of DMEF2 but very little of twist. Taken together, our results clearly indicate that there are inputs in addition to twist into the regulation of DMEF2 expression.
Comparison of Drosophila and vertebrate muscle transcription factors
A picture of the control of muscle development in vertebrate species is developing with both the MyoD and MEF2 families occupying pivotal points, although the relationship between them is unclear and the role of the MEF2 proteins is not yet established. There are striking parallels in the relationships between nautilus and the mammalian MyoD family and between DMEF2 and the mammalian MEF2 family. In each case, the Drosophila genome appears to contain only a single family member, whereas the mammalian genome contains four. At the level of the protein sequence, each has a very highly conserved DNA-binding and dimerisation motif, the bHLH region of the MyoD family and the MADSMEFZ domain of the MEF2 genes. Outside these domains there is little sequence similarity, although in both cases there are a number of short regions of conserved amino acids (Michelson et al., 1990; and not shown) . The expression pattern of nautilus resembles that of the mammalian MyoD family (Weintraub et al., 1991) , in that it is expressed early in the lineage and is restricted to somatic/skeletal muscle. Similarly, DMEF2, like the mammalian MEF2 family (Edmondson et al., 1994) , is expressed early in the variety of muscle types. One difference is that in mice, members of the MyoD family are expressed before those of the MEF2 family (Edmondson et al., 1994) , whereas DMEF2 is expressed well before nautilus in Drosophila. Nevertheless, the expression patterns of the MyoD and MEF2 family members in Drosophila, that is nautilus and DMEF2, are consistent with a role in muscle development.
We have emphasised the expression of DMEF2 in the developing musculature because this is the major site of expression. However, when the mesoderm is differentiating DMEF2 is transiently expressed in some cells that may not contribute to muscle, that is, some cells of the cross bridges and of the internal cell layer. During late embryogenesis, there may also be limited DMEF2 expression in the nervous system. At stage 16, although no expression is detected in the ventral nerve cord, we observe some staining associated with small areas of both the brain and peripheral nervous system (M.B. and M.V.T., unpublished results). Further work is required to character& these findings, but they are consistent with the observation that mammalian MEF2 genes are also expressed in the nervous system late in embryogenesis (Edmondson et al., 1994) .
Whilst this paper was in preparation, another study of DMEFZ was published which included a sequence of a single DMEF2 cDNA (Lilly et al., 1994) . The coding sequence is substantially the same as ours, although there are a number of discrepancies. There is a stretch of fourteen amino acids that differs from the sequence we report and which is due to a frame-shift resulting from a missing base at position 2108, followed by an extra base at position 2149. There are also three individual base differences (positions 1755, 1929 and 2502) that do not change the encoded amino acid. They also presented DMEF2 in situs which illustrated some of the points we have made. However, in contrast to our work, they concluded, without the benefit of double-labelling, that the patterns of expression of DMEF2 and twist are identical at stage 9 and comparable at stage 10.
We have presented a detailed description of the complex and dynamic distribution of DMEF2 throughout embryonic development. This provides a thorough basis for an analysis of DMEF2 function. One aspect to this which we are pursuing is the role of alternative splicing events. In adult mammalian tissues, some of the MEF2 alternative exons have a tissue-restricted pattern of expression (Yu et al., 1992; McDermott et al., 1993; Breibart et al., 1993) . However, nothing is known of the embryonic distribution of different alternatively spliced products nor of their function. More generally, the analysis of DMEF2 function will define the role of a MEF2 family member in muscle development and may uncover mechanisms that underlie the subdivision of the mesoderm. The similarity of DMEF2 to the vertebrate MEF2 genes suggests that such an analysis will be of general significance.
Experimental procedures
cDNA cloning and DNA sequencing
A 4-8 h Drosophila embryo cDNA library (Brown and Kafatos, 1988 ) was screened at low stringency with the 521-bp DraIIIIBstEII fragment from the Xenopus SL-1 cDNA (Chambers et al., 1992 ) that encompasses the DNA-binding domain of the encoded protein.
Hybridisation was in 5 x Denhardt's reagent, 6 x SSPE, 0.5% SDS at 6X, and the final wash was in 0.5 x SSC, 0.5% SDS at 42°C. After subcloning DMEF2 cDNAs into pBluescriptIIKS (-) (Stratagene), deletions were generated by exonuclease III digestion using the Erasea-base system (Promega). Single-and double-stranded templates were sequenced with custom synthesised or T3-or T7-promoter primers using Sequenase (USB). Each base was sequenced a minimum of two times from independent templates on each strand and an average of nine times. The sequence was assembled using the Staden Sequence Assemble Program and analysed using the UWGCG sequence analysis package.
Genomic Southern and chromosomal in situ hybridisation
16 pg of D.melanogaster genomic DNA was digested with BarnHI, EcoRI or Hind111 and fractionated on a 0.8% agarose TBE gel. The DNA was depurinated, denatured and neutralised before blotting onto Hybond-C extra nitrocellulose (Amersham). Hybridisation was in 5 x SSC, 0.1% N-lauryl sarcosine, 0.02% SDS, 1% blocking reagent (Boehringer) at 6O"C, and the final wash was in 0.5 x SSC/O.S% SDS at 42°C for 15 min for low stringency and in 0.1 x SSC/O.l% SDS at 65°C for high stringency. The DMEF2 probe was the 1188-bp PvuIIIBgflI fragment encompassing the conserved MEF2 domain, which was labelled with digoxygenin (Boehringer) by random priming and detected using a Lumi-phos chemiluminescence kit (Boehringer). In situ hybridisation to polytene chromosomes was carried out essentially as described in Ashbumer (1989) using a biotinylated probe of the entire DMEFZ cDNA.
RNA preparation and Northern blot
Total RNA was isolated from frozen embryos by a hot phenol method (Brown and Kafatos, 1988) and polyA+ RNA prepared from this using polyUSepharose (Pharmacia). The blot with polyA+ RNA was prepared as described (Hopwood et al., 1989) . Probes were labelled with [32P]-(rdATP using a Prime-It random primer kit (Stratagene). The DMEF2 probe was made from the DNA fragment described for the Southern blot. Final washes were in 0.2 x SSPE, 0.1% SDS at 65°C.
Whole mount embryo in situ hybridisation and antibody labelring
Whole mount in situ hybridisation with digoxygenin (Boehringer)-labelled probes was performed according to the method of Tautz and Pfeifle (1989) as modified by M. Ruiz-Gomez (Ruiz-Gomez and Ghysen, 1993) . The DMEF2 probe was that used for the Southern blot. Embryos were mounted in 90% glycerol and photographed on a Zeiss Axiophot microscope. Double-labelling for Twist protein and DMEF2 RNA was as described by Manoukian and Krause (1992) with the antibody staining before the in situ and with the following modifications: tRNA (250 pg/ml) was added only when incubating with the anti-Twist antibody, the secondary antibody and the ABC reagents; washes were for 30 min with several changes of buffer (1 x PBS, 0.1% Tween 20 and 50 &ml heparin). Anti-Twist antibody was kindly provided by Dr. Maria Leptin.
Ectopic activation of DMEF2
The yeast GAL4 system (Brand and Perrimon, 1993 ) was used to drive ectopic Twist expression. Flies carrying a UAS-twist construct (M.B. and M.Bate, unpublished results) were mated to flies carrying hsp70-GAL4 (a kind gift from Dr. A.Brand). O-l h embryos from this cross were collected, aged for 2 h at 25"C, heat-shocked at 37°C for 30 min and allowed to recover for 1.5-2 h. These embryos were fixed and processed for DMEF2 in situ hybridisation as described above.
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Note added in proof
The sequence we report will appear in the EMBL database under the accession number X83527. Whilst our paper was under review, Nguyen et al. also published a study of DMEF2 (Proc. Natl. Acad. Sci. USA 91, 7520-7524).
